SS
Shailendra Singh
About Shailendra Singh
Data last updated:
Shailendra Singh is an Additional Director at Rapross Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Rapross Pharmaceuticals Private Limited reported revenue of ₹29.39 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rapross Pharmaceuticals Private Limited U74899DL1995PTC066606 | Additional Director | 11 Aug 2025 | ₹29.39 Cr (FY 2023) | Active |
Board colleagues of Shailendra Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nimit Bansal | 10311245 | Rapross Pharmaceuticals Private Limited | Additional Director |
| Parveen Kumar Bansal | 07550240 | Rapross Pharmaceuticals Private Limited | Director |
| Ranjan Verma | 00180751 | Rapross Pharmaceuticals Private Limited | Director |
| Sharad Verma | 10311241 | Rapross Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shailendra Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shailendra Singh
Shailendra Singh currently holds 1 directorship: Rapross Pharmaceuticals Private Limited (Additional Director, since 11 Aug 2025, revenue ₹29.39 Cr (FY 2023)).
Shailendra Singh was first appointed on 11 Aug 2025 as Additional Director at Rapross Pharmaceuticals Private Limited.
The current boards of Shailendra Singh's companies include Nimit Bansal (Rapross Pharmaceuticals Private Limited), Parveen Kumar Bansal (Rapross Pharmaceuticals Private Limited), Ranjan Verma (Rapross Pharmaceuticals Private Limited), Sharad Verma (Rapross Pharmaceuticals Private Limited).